PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 4015695-1 1985 Diltiazem and verapamil were found to be inhibitors of the cytochrome P-450-dependent biotransformation of drugs. Diltiazem 0-9 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 59-75 9223567-1 1997 The antihypertensive agent diltiazem (DTZ) impairs hepatic drug metabolism by inhibition of cytochrome P450 (CYP). Diltiazem 27-36 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 92-107 9223567-1 1997 The antihypertensive agent diltiazem (DTZ) impairs hepatic drug metabolism by inhibition of cytochrome P450 (CYP). Diltiazem 27-36 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 109-112 9223567-1 1997 The antihypertensive agent diltiazem (DTZ) impairs hepatic drug metabolism by inhibition of cytochrome P450 (CYP). Diltiazem 38-41 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 92-107 9223567-1 1997 The antihypertensive agent diltiazem (DTZ) impairs hepatic drug metabolism by inhibition of cytochrome P450 (CYP). Diltiazem 38-41 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 109-112 9223567-3 1997 Thus, DTZ metabolites may contribute to CYP inhibition. Diltiazem 6-9 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 40-43 9223567-4 1997 This study assessed the role of human CYPs in microsomal DTZ oxidation and the capacity of DTZ metabolites to inhibit specific CYP activities. Diltiazem 57-60 cytochrome P450 family 4 subfamily F member 3 Homo sapiens 38-41